Conventional Fluid Management Versus Plethysmography Variability Index-based Goal-directed Fluid Management in Patients Undergoing Transurethral Resection of the Prostate
TURP
1 other identifier
interventional
58
1 country
1
Brief Summary
Transurethral resection of the prostate (TURP) is a widely performed surgical procedure for the management of benign prostatic hyperplasia. Because of the constant and frequently undetectable fluid exchange through the open prostatic venous sinuses, it is difficult to determine the precise amount of irrigating fluid absorbed after TURP surgery. Unpredictable intravascular volume changes may result from this. While over-resuscitation raises the risk of fluid overload, pulmonary edema, and cardiac events, under-resuscitation in older individuals can lead to hypotension and decreased organ perfusion. Fluid management in TURP has always depended on traditional techniques that employ clinical evaluations like blood pressure and heart rate monitoring or fixed-volume infusion procedures. By using advanced technologies, goal-directed fluid therapy (GDFT) methods continually monitor and evaluate a patient's physiological status in real time, modifying fluid dosage as necessary. A dynamic method for determining volume status, the plethysmography variability index (PVI) has been studied in numerous clinical settings and has proven reliable in predicting fluid responsiveness and acting as a fluid resuscitation guide
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2016
CompletedFirst Submitted
Initial submission to the registry
June 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
July 7, 2026
July 1, 2026
10.8 years
June 20, 2026
July 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The total amount of intraoperative crystalloid administered by each group.
the amount of crystalloids bottles given to the patient during the intra operative period
24 hours
Study Arms (2)
Conventional Fluid Management.
ACTIVE COMPARATORParticipants will receive conventional intraoperative fluid management according to the study protocol, based on mean arterial pressure (MAP) monitoring and fluid administration as clinically indicated.
PVI-Guided Goal-Directed Fluid Manage
EXPERIMENTALParticipants will receive intraoperative fluid management guided by Plethysmography Variability Index (PVI) measurements according to the study protocol, with fluid administration adjusted based on PVI values and hemodynamic parameters.
Interventions
Participants will receive conventional intraoperative fluid management according to the study protocol, based on mean arterial pressure (MAP) monitoring and fluid administration as clinically indicated.
Participants will receive intraoperative fluid management guided by Plethysmography Variability Index (PVI) measurements according to the study protocol, with fluid administration adjusted based on PVI values and hemodynamic parameters.
Eligibility Criteria
You may qualify if:
- Male patients aged from 50 to 80 years Scheduled for elective TURP.
- ASA Ⅰ, Ⅱ.
You may not qualify if:
- Cardiac arrhythmias (e.g., atrial fibrillation)
- Left ventricular ejection fraction \<40%
- Chronic kidney disease (stage ≥ 3)
- Hepatic dysfunction
- Peripheral vascular disease
- Prolonged procedures more than 2 hours or complicated procedures with severe bleeding affecting management (Severe bleeding will be defined as any of the following: a drop in hemoglobin of ≥ 2 g/dl, hemodynamic instability due to blood loss that requires blood transfusion).
- Patients refuse to share in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University Hospitals Anesthesia Department
Cairo, Egypt
Related Publications (3)
Kadir Arslan ASŞ. Transurethral Resection of the Prostate (TURP) Syndrome: A Review of Perioperative Management. Comprehensive Medicine 2024;16(2):123-7.
BACKGROUNDPandya DS. TURP Syndrome. Practical Guidelines on Fluid Therapy. Third ed2024. p. 537-43.
BACKGROUNDTapscott AH, Hakim LS. Office-based management of impotence and Peyronie's disease. Urol Clin North Am. 2013 Nov;40(4):521-43. doi: 10.1016/j.ucl.2013.07.003. Epub 2013 Sep 3.
PMID: 24182973BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mariam saeed toukhy, master degree of anesthesia
anesthesia department at cairo univesrsity hospitals
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This randomized controlled trial (RCT) aims to compare the clinical outcomes of conventional fluid management with PVI-based GDFT in patients undergoing TURP. We hypothesize that PVI-guided fluid management will result in better intraoperative hemodynamic stability, a reduction in postoperative complications, and an overall improvement in patient recovery.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 20, 2026
First Posted
June 25, 2026
Study Start
March 15, 2016
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
July 7, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
No plan for sharing individual participant data has been developed for this study